Shenzhen Geno-Immune Medical Institute   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Shenzhen China (2014)

Organization Overview

First Clinical Trial
2014
NCT03050190
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Shenzhen Genoimmune Medical Institute | Shenzhen Geno-Immune Medical Institute